分子量マーカーの世界市場：DNAマーカー、プロテイン・マーカー、RNAマーカー...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 MARKET SIZE ESTIMATION 21
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.3 MARKET SHARE ESTIMATION 25
2.3.1 KEY DATA FROM SECONDARY SOURCES 25
2.3.2 KEY DATA FROM PRIMARY SOURCES 25
2.3.3 ASSUMPTIONS 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 31
4.1 MOLECULAR WEIGHT MARKERS MARKET TO GROW AT A HIGH RATE 31
4.2 LIFE CYCLE ANALYSIS, BY REGION (2014) 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 35
5.2 MARKET SEGMENTATION 35
5.2.1 MOLECULAR WEIGHT MARKERS MARKET, BY PRODUCT 35
5.2.2 MOLECULAR WEIGHT MARKERS MARKET, BY TYPE 35
5.2.3 MOLECULAR WEIGHT MARKERS MARKET, BY APPLICATION 36
5.2.4 MOLECULAR WEIGHT MARKERS MARKET, BY END USER 37
5.3 MARKET DYNAMICS 37
5.3.1 DRIVERS 38
5.3.1.1 Increased research and development spending by biotechnology companies 38
5.3.1.2 Research funding in public sector 38
5.3.1.3 Proteomics and genomics technologies research 38
5.3.1.4 Growing partnership between academic institutes and biotechnology & pharmaceutical companies for molecular research 39
 
5.3.2 RESTRAINTS 39
5.3.2.1 Highly consolidated market restricts the entry of new firms 39
5.3.2.2 Lack of skilled professionals 39
5.3.3 OPPORTUNITIES 39
5.3.3.1 Emerging and untapped markets 39

6 INDUSTRY TRENDS 40
6.1 INTRODUCTION 40
6.2 PORTER’S FIVE FORCES ANALYSIS 40
6.2.1 THREAT FROM NEW ENTRANTS 41
6.2.2 THREAT FROM SUBSTITUTES 41
6.2.3 BARGAINING POWER OF BUYERS 41
6.2.4 BARGAINING POWER OF SUPPLIERS 41
6.2.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 41
6.3 STRATEGIC BENCHMARKING 42
6.3.1 EXPANSION 42
6.4 SUPPLY CHAIN ANALYSIS 43
6.4.1 KEY INFLUENCERS 44

7 MOLECULAR WEIGHT MARKERS MARKET, BY PRODUCT 45
7.1 INTRODUCTION 46
7.2 PRODUCT SEGMENTATION 46
7.2.1 DNA MARKERS 47
7.2.2 PROTEIN MARKERS 51
7.2.3 RNA MARKERS 55
7.3 MARKET, BY TYPE 56
7.3.1 PRESTAINED MARKERS 57
7.3.2 UNSTAINED MARKERS 58
7.3.3 SPECIALTY MARKERS 59

8 MOLECULAR WEIGHT MARKERS MARKET, BY APPLICATION 61
8.1 INTRODUCTION 62
8.2 NUCLEIC ACID APPLICATIONS 64
8.2.1 MOLECULAR CLONING 66
8.2.2 POLYMERASE CHAIN REACTION (PCR) 67
8.2.3 SEQUENCING 68
8.2.4 NORTHERN BLOTTING 70
8.2.5 SOUTHERN BLOTTING 71
8.2.6 OTHER APPLICATIONS 72
8.3 PROTEIN APPLICATIONS 73

9 MOLECULAR WEIGHT MARKERS MARKET, BY END USER 76
9.1 INTRODUCTION 77
9.2 ACADEMIC RESEARCH INSTITUTES 78
9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 80
9.4 CONTRACT RESEARCH ORGANIZATIONS 82
9.5 OTHER END USERS 84

10 GEOGRAPHIC ANALYSIS 85
10.1 INTRODUCTION 86
10.2 NORTH AMERICA 87
10.3 EUROPE 97
10.4 ASIA 106
10.5 REST OF THE WORLD (ROW) 116

11 COMPETITIVE LANDSCAPE 125
11.1 INTRODUCTION 125
11.2 MARKET SHARE ANALYSIS: MOLECULAR WEIGHT MARKERS MARKET 126
11.3 COMPETITIVE SITUATION AND TRENDS 128
11.3.1 EXPANSIONS 128
11.3.2 OTHER DEVELOPMENTS 131
11.3.3 AGREEMENTS AND JOINT VENTURES 132
11.3.4 ACQUISITIONS 133

12 COMPANY PROFILES 134
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 INTRODUCTION 134
12.2 AGILENT TECHNOLOGIES 135
12.3 BIO-RAD LABORATORIES 138
12.4 F. HOFFMANN-LA ROCHE LTD. 141
12.5 SIGMA-ALDRICH CORPORATION 144
12.6 THERMO FISHER SCIENTIFIC, INC. 148
12.7 AFFYMETRIX, INC. 153
12.8 NEW ENGLAND BIOLABS, INC. 155
12.9 PROMEGA CORPORATION 158
12.10 QIAGEN N.V. 160
12.11 TAKARA BIO, INC. 162
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

13 APPENDIX 164
13.1 INSIGHTS OF INDUSTRY EXPERTS 164
13.2 DISCUSSION GUIDE 165
13.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 167
13.4 AVAILABLE CUSTOMIZATIONS 168
13.5 RELATED REPORTS 169